Catherine H Vu - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 31, 2022

Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI)Catherine H Vu, Veena Venugopalan, Barbara A Santevecchi, et al.

Jac-Antimicrobial Resistance|March 20, 2023

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)Alexander C Branton, Catherine H Vu, Veena Venugopalan, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 31, 2022

Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI)Catherine H Vu, Veena Venugopalan, Barbara A Santevecchi, et al.

Jac-Antimicrobial Resistance|March 20, 2023

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)Alexander C Branton, Catherine H Vu, Veena Venugopalan, et al.

Pageof 1